Sees FY23 diluted earnings per common share of 52c-58c; diluted Nareit FFO share of $1.70-$1.76; total portfolio Same-Store cash adjusted NOI growth of 2.75%-4.25%. Components of Total Portfolio Same-Store Cash Adjusted NOI guidance are Life Science: 3.0% to 4.5%; 47% of the FY23 same-store pool; Medical Office: 2.0% to 3.0%; 42% of the FY23 same-store pool; CCRC: 5.0% to 10.0%; 11% of the FY23 same-store pool.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PEAK:
- Healthpeak Properties Reports Fourth Quarter and Year Ended 2022 Results
- Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock
- Healthpeak upgraded to Buy at Jefferies with stability prioritized
- Healthpeak upgraded to Buy from Hold at Jefferies
- Healthpeak downgraded to Sector Perform from Outperform at RBC Capital